Skip to main content
May 21, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Olaparib
Ovarian Cancer Treatment
Update on PARP Inhibitors & Other Precision Cancer Medicines for Ovarian Cancer
By Dr. C.H. Weaver M.D.
Sep 30, 2021
Breast Cancer Treatment
PARP Inhibitors improve outcomes in BRCA mutated breast cancer. FDA approves Lynparza for treatment of TNBC and early stage breast cancer.
By Dr. C.H. Weaver M.D.
Apr 30, 2022
Prostate Cancer Treatment
PARP Inhibitors - Effective in Men with BRCA-Mutant Prostate Cancer
By Dr. C.H. Weaver M.D.
Feb 19, 2022
Ovarian Cancer Treatment
Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer
By Dr. C.H. Weaver M.D.
Nov 19, 2021
Ovarian Cancer Overviews
Treatment & Management of Ovarian Cancer
By Dr. C.H. Weaver M.D.
Sep 30, 2021
Ovarian Cancer Treatment
Rubraca Significantly Improves Ovarian Cancer Treatment
By Dr. C.H. Weaver M.D.
Apr 1, 2022
CLOSE
CLOSE
CLOSE
CLOSE